Sri Lanka approves Pfizer-BioNTech COVID vaccine for emergency use
[File: Dado Ruvic / Illustration / Reuters]
Approval for this mRNA-based COVID-19 jab was granted by National Medicines Regulatory Authority (NMRA).
Germany-based biotechnology BioNTech, the developer of the vaccine, had collaborated with the American multinational pharmaceutical corporation Pfizer for support with clinical trials, logistics, and manufacturing of the vaccine.
According to the World Health Organization, the Pfizer-BioNTech vaccine against COVID-19 has an efficacy of 95% against symptomatic SARS-CoV-2 infection.
State Minister of Primary Health Care, Epidemics and COVID Disease Control Dr. Sudarshini Fernandopulle stated that Sri Lanka plans to import 5 million doses of Pfizer-BioNTech coronavirus vaccine.
Given the COVID-19 pandemic situation in India aggravated by the current wave, the Serum Institute is now unable to provide Oxford-AstraZeneca’s Covishield vaccine supplies to other countries, State Minister Fernandopulle said.
As a result, Sri Lanka is faced with the challenge of procuring the Covishield vaccines, she pointed out further.
(Source: Ada Derana)
Latest Headlines in Sri Lanka
- Sri Lanka President says true independence lies in economic freedom, unity February 4, 2026
- Sri Lanka grants special presidential pardon to 49 inmates February 4, 2026
- President Anura Kumara Dissanayake’s 78th National Independence Day message February 4, 2026
- Sri Lanka moves to strengthen fight against money laundering and terror financing February 3, 2026
- L.S.P. Jayaratne approved as Auditor General by Constitutional Council February 3, 2026
Would you like to share any new test methods and new found data other countries approved this months ago have not found?
They are fumbling.
It is becoming obvious that vaccines sposored by the already rich are of no value.
Learn from the outcomes of the Spanish Flu.
Learn from the outcomes of the SARS Hong Kong.
We, as a society, have learn to enhance social prevention, HYGIENE and adopt new habits to conquer CV19.